• 목록
• 답변
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There isn't much information on how long-term exposure to these medications can affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus do not develop neurological developmental disorders like hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication must evaluate the benefits of using it versus the risks for the baby. Physicians don't have the data to make unambiguous recommendations however they can provide information about risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy did not have a higher risk of fetal malformations, or structural birth defects. The researchers used a large population-based study of case-control to evaluate the incidence of major structural birth defects in babies born to mothers who took stimulants during the early stages of pregnancy and those who had not. Clinical geneticists, pediatric cardiologists and other experts examined the cases to confirm that the classification was accurate and to reduce any bias.

The research conducted by the researchers was not without its limitations. The researchers were unable in the beginning, to separate the effects of the medication from the disorder. This limitation makes it difficult for researchers to determine whether the small associations observed among the groups exposed were due to the use of medication or if they were confounded by the presence of comorbidities. In addition the study did not examine the long-term outcomes of offspring.

The study did reveal that babies whose mothers had taken ADHD medications during pregnancy were at slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or cut back on their medications prior to or during pregnancy. This was due to central nervous system-related disorders and the increased risk for admission was not found to be influenced by which stimulant medication was used during pregnancy.

Women who took stimulant ADHD medication during pregnancy were also at an increased chance of having a caesarean delivery or having a child with low Apgar score (less than 7). These increases appear to be independent of the type of medication taken during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefit to both mother and child of continued treatment for the woman's condition. Physicians should discuss the issue with their patients and, where they are able, assist them in developing strategies for improving their coping skills that can lessen the negative impact of her condition on her daily functioning and relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and being treated with medication, the dilemma of whether to continue or discontinue treatment during pregnancy is one that doctors are having to have to face. These decisions are usually made without clear and authoritative evidence. Instead, doctors must consider their own expertise, the experience of other doctors and the research on the topic.

Particularly, the subject of potential risks for the baby can be tricky. The research on this subject is based on observations rather than controlled studies and a lot of the results are conflicting. Additionally, the majority of studies limit their analysis to live births, which can underestimate the severity of teratogenic effects that could cause abortion or termination of the pregnancy. The study discussed in this journal club addresses these shortcomings by examining data on both live and deceased births.

Conclusion: While some studies have found an association between concerta adhd medication medications and certain birth defects, other studies have not established a link. The majority of studies show an unintended, or somewhat negative, impact. In all cases, a careful analysis of the potential risks and benefits is required.

It can be challenging, if not impossible for women with adhd medication private prescription to stop taking their medication. In a recent article in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of loneliness and family conflict for patients with ADHD. A decrease in medication could also impact the ability to drive safely and perform work-related tasks, which are crucial aspects of everyday life for those suffering from ADHD.

She suggests women who are unsure about whether to continue or stop taking medication because of their pregnancy should consider educating family members, friends and colleagues about the condition, its effects on daily life, and the benefits of keeping the current treatment plan. It can also help women feel supported in her decision. It is important to remember that some medications are able to pass through the placenta, so if a woman decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the drug can be transferred to the infant.

Birth Defects and Risk of

As the use of Adhd Medication Pregnancy medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns about what impact the drugs could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this topic. Researchers used two massive data sets to study over 4.3 million pregnancies and determine whether stimulant medications increased birth defects. Researchers discovered that, while the overall risk is low, first-trimester ADHD medication use was associated with slightly higher rates of specific heart defects like ventriculoseptal defects.

The authors of the study could not discover any connection between the use of early medications and other congenital anomalies such as facial deformities or club feet. The results are in line with previous studies that have shown the presence of a small, but significant increase in the risk of developing cardiac malformations in women who started taking best adhd medication for adults with anxiety and depression medications before pregnancy. The risk was higher during the latter part of pregnancy, when many women are forced to stop taking their ADHD medications.

Women who took ADHD medication during the first trimester were more likely require a caesarean birth, have an insufficient Apgar after delivery and have a baby that needed breathing assistance at birth. The researchers of the study could not remove bias in selection since they limited their study to women who did not have any other medical conditions that could have contributed to the findings.

Researchers hope that their study will provide doctors with information when they meet pregnant women. The researchers advise that while discussing benefits and risks are crucial, the decision regarding whether or not to stop medication should be made in light of the severity of each woman's ADHD symptoms and her requirements.

The authors also warn that even though stopping the medication is an option, it isn't an option that is recommended due to the high rate of depression and other mental health issues for women who are expecting or who are recently postpartum. Additionally, the research suggests that women who choose to stop taking their medications are more likely to experience difficulties adjusting to life without them after the birth of their baby.

Nursing

The responsibilities that come with being a new mother can be overwhelming. Women with ADHD who have to manage their symptoms while attending physician appointments and getting ready for the arrival of their child and adapting to new routines in the home may face a lot of challenges. This is why many women elect to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant medicines are absorbed through breast milk in small amounts, therefore the risk to the breastfeeding infant is minimal. The rate of exposure to medication will differ based on dosage the medication is administered, its frequency and time of day. Additionally, different drugs enter the infant's system through the gastrointestinal tract or breast milk. The impact on the health of a newborn is not completely known.

Due to the absence of evidence, some doctors might be tempted to stop taking stimulant medications during the pregnancy of a woman. This is a difficult decision for the patient, who must balance the benefit of continuing her medication against the possible risks to the foetus. As long as there is no more information, doctors should inquire with all pregnant patients about their history of ADHD and whether they are taking or planning to take medication during the perinatal time.

A growing number of studies have shown that the majority of women are able to safely continue their ADHD medication during pregnancy and while breastfeeding. In response, an increasing number of patients are opting to continue their medication. They have concluded after consulting with their physicians that the benefits of keeping their current medication far outweigh any potential risks.

Women who suffer from ADHD who plan to breastfeed should seek the advice of an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor as well as the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also required to help pregnant women with ADHD be aware of the symptoms and the underlying disorder. They should also be informed about treatment options and reinforce the coping mechanisms. This should be a multidisciplinary approach with the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counseling should include a discussion of a treatment plan for the mother and child, and monitoring for signs of deterioration and, if needed, adjustments to the medication regimen.